Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy

NCT00615290 · clinicaltrials.gov ↗

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: tipranavir

Sponsor

Boehringer Ingelheim